Fulviglen 250 mg PFS
111,68$
73,66$
Fulviglen 250 mg PFS is an injectable anticancer treatment specifically designed for postmenopausal women battling breast cancer. This medication is particularly effective when combined with palbociclib, targeting hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer that is locally advanced or has metastasized after previous endocrine therapies. The active ingredient in Fulviglen works by decreasing estrogen levels in the body, which helps to inhibit the proliferation of cancer cells. It is essential for patients to discuss their complete medical history with their healthcare provider, as Fulviglen may present certain risks and side effects. Regular monitoring during treatment is crucial to ensure safety and efficacy. By understanding its mechanism and potential interactions, patients can better navigate their cancer treatment journey. Always consult with a healthcare professional before starting any new medication, including Fulviglen, to ensure it aligns with your treatment goals.
Quantité
Active Pharmaceutical Ingredient
Uses
• Fulviglen 250 mg pfs is primarily utilized in the management of symptoms associated with breast cancer. Patients experiencing discomfort from lumps or thickening in the breast or underarm area may find relief through this medication. It helps in alleviating the physical manifestations of the disease, thereby improving the quality of life. Fulviglen 250 mg pfs plays a supportive role in the overall treatment regimen for breast cancer.
• Another significant use of Fulviglen 250 mg pfs is to address changes in the size or shape of the breast due to cancer progression. These alterations can be distressing for patients, both physically and emotionally. By managing these symptoms, Fulviglen 250 mg pfs can contribute to a more stable condition and a better body image for individuals undergoing treatment. This aspect is crucial for maintaining mental well-being during cancer therapy.
• Fulviglen 250 mg pfs also assists in managing dermatological symptoms related to breast cancer, such as skin changes on the breast or nipple. Symptoms like redness or scaling can be uncomfortable and may affect a patient’s self-esteem. By treating these skin issues, Fulviglen 250 mg pfs helps enhance the overall comfort of patients. This supportive care is essential in the holistic treatment of breast cancer.
• In various clinical scenarios, Fulviglen 250 mg pfs can be integrated into a comprehensive treatment plan for breast cancer patients. It serves as an adjunct therapy, complementing other treatments to ensure symptom relief. By addressing both physical and emotional aspects of the disease, Fulviglen 250 mg pfs aids in creating a more manageable treatment experience. Its role is vital in supporting patients through their cancer journey.
Benefits
Fulviglen PFS Injection effectively reduces the symptoms associated with breast cancer, such as breast lumps, bloody nipple discharge, or changes in the shape or texture of the breast. Its mechanism of action involves altering the production of hormones that are essential for the growth and metastasis of breast cancer cells. It may also interact with other hormones or directly inhibit cancer growth. It is essential to receive Fulviglen 250 PFS Injection by injection from a doctor or nurse as self-administration is not recommended.It is important to look at your doctor's instructions carefully.
Side Effects
As with all medicines, Fulviglen 250 mg PFS may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.
Most Common Side Effects
• Back pain
• Diarrhoea
• Vaginal bleeding
• Muscle and Joint pain
• Reaction in the injection site
• Vomiting
• Nausea
• Numbness
• Appetite loss
• Sweating
• Infection in the urinary tract
Common Side Effects
• Blood clots
• Low platelets count
• Liver failure
• Swelling in tongue, mouth, throat, and face
How To Use
The Fulviglen 250 mg PFS is administered by a healthcare professional or nurse in a hospital or clinic setting by intravenous infusion under the skin. The specific dosage and administration of Fulviglen 250 mg PFS Injection will be determined by the patient's clinical condition, age, medical history, and other factors. It is important to note that this Fulviglen 250 mg should not be self-administered, and it is important to follow the instructions of the healthcare professional administering the Fulviglen 250 mg PFS Injection.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Fulviglen PFS Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Fulviglen 250 mg should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Fulviglen 250 mg PFS Injection and report any unusual symptoms or changes in kidney function to their doctor. The dose of Fulviglen 250 mg may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Fulviglen 250 PFS Injection. Fulviglen PFS Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Fulviglen 250 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Fulviglen 250 PFS Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Fulviglen 250 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Fulviglen 250 PFS Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Fulviglen 250 mg PFS Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Fulviglen 250 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Fulviglen 250 mg PFS is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Fulviglen 250 PFS Injection such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.